Molecular formula: | C39H67N5O6 |
Average mass: | 701.994 |
Monoisotopic mass: | 701.509135 |
ChemSpider ID: | 5293519 |
8 of 8 defined stereocentres
149606-27-9
[RN]DQC51A0WQH
[UNII]L-Valinamide, N,N-dimethyl-L-valyl-N-((1S,2R)-2-methoxy-4-((2S)-2-((1R,2R)-1-methoxy-2-methyl-3-oxo-3-((2-phenylethyl)amino)propyl)-1-pyrrolidinyl)-1-((1S)-1-methylpropyl)-4-oxobutyl)-N-methyl-
L-Valinamide, N,N-dimethyl-L-valyl-N-[(1S,2R)-2-methoxy-4-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[(2-phenylethyl)amino]propyl]-1-pyrrolidinyl]-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-
[ACD/Index Name]N,N-Dimethyl-L-valyl-N-{(3R,4S,5S)-3-methoxy-1-[(2S)-2-{(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[(2-phenylethyl)amino]propyl}-1-pyrrolidinyl]-5-methyl-1-oxo-4-heptanyl}-N-methyl-L-valinamid
[German]
[ACD/IUPAC Name]N,N-Dimethyl-L-valyl-N-{(3R,4S,5S)-3-methoxy-1-[(2S)-2-{(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[(2-phenylethyl)amino]propyl}-1-pyrrolidinyl]-5-methyl-1-oxo-4-heptanyl}-N-methyl-L-valinamide
[ACD/IUPAC Name]N,N-Diméthyl-L-valyl-N-{(3R,4S,5S)-3-méthoxy-1-[(2S)-2-{(1R,2R)-1-méthoxy-2-méthyl-3-oxo-3-[(2-phényléthyl)amino]propyl}-1-pyrrolidinyl]-5-méthyl-1-oxo-4-heptanyl}-N-méthyl-L-valinamide
[French]
[ACD/IUPAC Name]soblidotin
[INN]soblidotina
[Spanish]
[INN]soblidotine
[French]
[INN]soblidotinum
[Latin]
[INN]соблидотин
[Russian]
[INN]سوبليدوتين
[Arabic]
[INN]索利多丁
[Chinese]
[INN](2S)-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-N-[(3R,4S,5S)-3-methoxy-1-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-(2-phenylethylamino)propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide
auristatin PE
N,N-dimethyl-L-valyl-N-{(3R,4S,5S)-3-methoxy-1-[(2S)-2-{(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[(2-phenylethyl)amino]propyl}pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl}-N-methyl-L-valinamide
soblidotina
soblidotine
soblidotinum
Soblitodin
соблидотин
سوبليدوتين
索利多丁